Mark Jones, Executive Director, bought 500,000 shares in the company on the 16th March 2020 at a price of 93.41p. The Director now holds 1,434,438...

Luke Ellis, Chief Executive Officer, bought 123,018 shares in the company on the 16th March 2020 at a price of 94.99p. The Director now holds...

Luke Ellis, Chief Executive Officer, bought 626,982 shares in the company on the 17th March 2020 at a price of 95.00p. The Director now holds...

Richard Studwell, Non Executive Director, bought 1,000 shares in the company on the 17th March 2020 at a price of 263.00p. The Director now holds...

UBS today reaffirms its buy investment rating on Rolls-Royce Group PLC (LON:RR.) and cut its price target to 664p (from 886p).

Broker Forecasts data provided...

James Dickson, Chairman, bought 15,000 shares in the company on the 16th March 2020 at a price of 100.00p. The Director now holds 5,034,981 shares....

Simon Holden, Non Executive Director, bought 17,500 shares in the company on the 17th March 2020 at a price of 149.30p. The Director now holds...

Christopher Townsend, Non Executive Director, bought 15,000 shares in the company on the 13th March 2020 at a price of 745.00p. The Director now holds...

Christopher Townsend, Non Executive Director, bought 25,000 shares in the company on the 16th March 2020 at a price of 713.00p. The Director now holds...

Drug discovery company E-therapeutics narrowed full-year losses as it cut back on R&D and administrative spending.

Pre-tax losses for the year through January amounted to...